AbCellera
AbCellera is a Vancouver, British Columbia-based biotechnology firm that researches and develops human antibodies to address pandemics and common diseases. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Q24639
Vancouver, British Columbia
LOC
Q12184
pandemic
Concept
None
Pandemic Prevention Platform
UNK
Q207361
DARPA
Concept
Q48797966
Biological Technologies Office
UNK
Q391028
University of British Columbia
LOC
Q30271491
AbCellera
MEDIA
Q30271491
AbCellera
MEDIA
+60^^http://www.w3.org/2001/XMLSchema#decimal
60
NUMBER
headquarters location